These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 7002602)

  • 1. [Adrenergic receptors of the neurons in the vertebrate brain (a review of the literature)].
    Komissarov IV
    Farmakol Toksikol; 1980; 43(2):230-8. PubMed ID: 7002602
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacological characterization of dopamine "autoreceptors" by microiontophoretic single-cell recording studies.
    Aghajanian GK; Bunney BS
    Adv Biochem Psychopharmacol; 1977; 16():433-8. PubMed ID: 883551
    [No Abstract]   [Full Text] [Related]  

  • 3. Modulation of the beta-adrenergic receptor-adenylate cyclase system following acute and repeated treatment with antidepressants.
    Weiss B; Heydorn W; Frazer A
    Adv Biochem Psychopharmacol; 1982; 31():37-53. PubMed ID: 6282063
    [No Abstract]   [Full Text] [Related]  

  • 4. Receptors acting through adenylate cyclase in the CNS.
    Wollemann M
    Acta Physiol Acad Sci Hung; 1980; 55(4):299-304. PubMed ID: 6258390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mianserin: direct activation of brain norepinephrine neurons by blocking alpha 2-receptors.
    Engberg G; Svensson TH
    Commun Psychopharmacol; 1980; 4(3):233-9. PubMed ID: 6262009
    [No Abstract]   [Full Text] [Related]  

  • 6. [Functional role of noradrenergic neurons in the hypothermic effect of apomorphine and other dopaminomimetics].
    Shchelkunov EL; Andreeva OG; Korovin KF; Ostroumova MN
    Farmakol Toksikol; 1980; 43(5):558-63. PubMed ID: 7449984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Morphological restructurings in the brain due to a decrease in the catecholamine level].
    Otellin VA; Kucherenko RP; Gilerovich EG; Usova IP; Fedosikhina LA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(7):978-81. PubMed ID: 6089476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation and adaptation of central norepinephrine receptor systems: modification by antidepressant treatments.
    Sulser F
    Psychiatr J Univ Ott; 1982 Sep; 7(3):196-203. PubMed ID: 6294716
    [No Abstract]   [Full Text] [Related]  

  • 9. Development of stimulus-secretion coupling in salivary glands.
    Cutler LS; Christian CP; Bottaro B
    Methods Cell Biol; 1981; 23():531-45. PubMed ID: 7329330
    [No Abstract]   [Full Text] [Related]  

  • 10. Mode of action of antidepressant drugs.
    Sulser F
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):14-20. PubMed ID: 6406444
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effector cell adrenoreceptors--local regulators of the intensity of the adrenergic reaction].
    Manukhin BN
    Fiziol Zh SSSR Im I M Sechenova; 1984 May; 70(5):609-16. PubMed ID: 6088304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain reinforcement mechanisms: alpha-adrenergic and dopaminergic agonists and antagonists.
    Wauquier A; Clincke G; Fransen J
    Prog Clin Biol Res; 1981; 71():177-96. PubMed ID: 7330078
    [No Abstract]   [Full Text] [Related]  

  • 13. Critical role of alpha1-adrenergic receptors in acute and sensitized locomotor effects of D-amphetamine, cocaine, and GBR 12783: influence of preexposure conditions and pharmacological characteristics.
    Drouin C; Blanc G; Villégier AS; Glowinski J; Tassin JP
    Synapse; 2002 Jan; 43(1):51-61. PubMed ID: 11746733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central pre- and postsynaptic 5-HT1A receptors in rats treated chronically with a novel antidepressant, cericlamine.
    Jolas T; Haj-Dahmane S; Kidd EJ; Langlois X; Lanfumey L; Fattaccini CM; Vantalon V; Laporte AM; Adrien J; Gozlan H
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1432-43. PubMed ID: 8138956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospects for research on schizophrenia. V. Pharmacological observations, Drug-induced psychoses.
    Snyder SH; Aghajanian GK; Matthysse S
    Neurosci Res Program Bull; 1972 Nov; 10(4):430-45. PubMed ID: 4663824
    [No Abstract]   [Full Text] [Related]  

  • 16. Bupropion: a review of its mechanism of antidepressant activity.
    Ascher JA; Cole JO; Colin JN; Feighner JP; Ferris RM; Fibiger HC; Golden RN; Martin P; Potter WZ; Richelson E
    J Clin Psychiatry; 1995 Sep; 56(9):395-401. PubMed ID: 7665537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine receptors: a review.
    Woodruff GN
    Comp Gen Pharmacol; 1971 Dec; 2(8):439-55. PubMed ID: 4147044
    [No Abstract]   [Full Text] [Related]  

  • 18. Mu- and delta-opioid receptors inhibitorily linked to dopamine-sensitive adenylate cyclase in rat striatum display a selectivity profile toward endogenous opioid peptides different from that of presynaptic mu, delta and kappa receptors.
    Schoffelmeer AN; De Vries TJ; Hogenboom F; Mulder AH
    J Pharmacol Exp Ther; 1993 Oct; 267(1):205-10. PubMed ID: 8229747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Adrenergic control of adipocyte metabolism].
    Lafontan M; Berlan M
    Ann Endocrinol (Paris); 1983; 44(5):291-4. PubMed ID: 6372637
    [No Abstract]   [Full Text] [Related]  

  • 20. Amygdaloid D1 receptors are not linked to stimulation of adenylate cyclase.
    Leonard SK; Anderson CM; Lachowicz JE; Schulz DW; Kilts CD; Mailman RB
    Synapse; 2003 Dec; 50(4):320-33. PubMed ID: 14556237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.